Crinetics Pharmaceuticals CRNX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's change in AP?
- Crinetics Pharmaceuticals (CRNX) reported change in AP of -$12.06M in Q1 2026.
- How has Crinetics Pharmaceuticals's change in AP changed year-over-year?
- Crinetics Pharmaceuticals's change in AP decreased by 789.7% year-over-year, from -$1.36M to -$12.06M.
- What is the long-term trend for Crinetics Pharmaceuticals's change in AP?
- Over 2 years (2021 to 2024), Crinetics Pharmaceuticals's change in AP has grown at a 45.5% compound annual growth rate (CAGR), from $6.29M to $13.32M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.